Dot1L-IN-2

Modify Date: 2024-01-15 11:18:17

Dot1L-IN-2 Structure
Dot1L-IN-2 structure
Common Name Dot1L-IN-2
CAS Number 1940206-71-2 Molecular Weight 476.53
Density N/A Boiling Point N/A
Molecular Formula C27H24N8O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Dot1L-IN-2


Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively.

 Names

Name Dot1L-IN-2

 Dot1L-IN-2 Biological Activity

Description Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively.
Related Catalog
Target

IC50: 0.4 nM (Dot1L)[1] Ki: 0.08 nM (Dot1L)[1]

In Vitro Dot1L-IN-2 is a potent, selective Dot1L inhibitor, with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively. Dot1L-IN-2 potently inhibits H3K79 dimethylation (IC50, 16 nM), and blocks the activity of the HoxA9 promoter (IC50, 340 nM) in cellular systems. Dot1L-IN-2 also dramatically suppresses proliferation of the human MLL-rearranged leukemia cell line MV4-11 carrying the oncogenic MLL-AF4 fusion (IC50, 128 nM)[1].
References

[1]. Chen C, et al. Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach. ACS Med Chem Lett. 2016 Jun 1;7(8):735-40.

 Chemical & Physical Properties

Molecular Formula C27H24N8O
Molecular Weight 476.53
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.